Evidence map›Paper›PMID 42164857›Full record

ArticleiScience2026

Tumor microenvironment responsive copper-doped carbon dots for synergistic chemotherapy and cuproptosis in laryngeal cancer.

Jiali He, Yanghao Hu, Pengfei Liu, Da Li, Yanqi Huang, Junlei Liu, Zihao Xia, Hongshuai Liu, Wenying Li, Zhisen Shen

Abstract read
In one paragraph

Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jiali HeThe Affiliated Lihuili Hospital of Ningbo University, Ningbo University, Ningbo 315040, China.
Yanghao HuThe Affiliated Lihuili Hospital of Ningbo University, Ningbo University, Ningbo 315040, China.
Pengfei LiuThe Affiliated Lihuili Hospital of Ningbo University, Ningbo University, Ningbo 315040, China.
Da LiThe Affiliated Lihuili Hospital of Ningbo University, Ningbo University, Ningbo 315040, China.
Yanqi HuangThe Affiliated Lihuili Hospital of Ningbo University, Ningbo University, Ningbo 315040, China.
Junlei LiuSchool of Materials Science and Chemical Engineering, Ningbo University, Ningbo, China.
Zihao XiaThe Affiliated Lihuili Hospital of Ningbo University, Ningbo University, Ningbo 315040, China.
Hongshuai LiuThe Affiliated Lihuili Hospital of Ningbo University, Ningbo University, Ningbo 315040, China.
Wenying LiSchool of Materials Science and Chemical Engineering, Ningbo University, Ningbo, China.
Zhisen ShenThe Affiliated Lihuili Hospital of Ningbo University, Ningbo University, Ningbo 315040, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Laryngeal squamous cell carcinoma (LSCC) has a poor prognosis because it is often diagnosed late, and chemotherapy causes substantial side effects. To improve efficacy and reduce toxicity, we developed a tumor microenvironment-responsive nanoplatform, 5-fluorouracil-loaded copper-doped carbon dots (5-Fu@CuCDs). The nanocomposite was synthesized by a one-step hydrothermal method, showed a uniform spherical morphology of about 15.7 nm, and achieved a drug loading rate of about 30%. Structural analyses confirmed successful copper doping and stable drug incorporation. Under weakly acidic tumor microenvironment conditions, the nanoplatform catalyzed hydroxyl radical generation from hydrogen peroxide and depleted intracellular glutathione, thereby enhancing oxidative stress. Density functional theory calculations further supported its high peroxidase-like catalytic activity.

Indexed as

cell biologydrug delivery systemmaterials sciencenanotechnologyoncology

Identifiers

PMID42164857
PMCPMC13186080

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.